Apollomics (APLM) Current Leases (2021 - 2025)
Apollomics' (APLM) quarterly Current Leases came in at $209000.0 in Q4 2025, down 10.3% year-over-year from $233000.0 in Q4 2024, and up 2.96% quarter-over-quarter from $203000.0 in Q2 2025.
Analysis
Apollomics (APLM) Current Leases (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Current Leases for 5 consecutive years, with $209000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Current Leases fell 10.3% year-over-year to $209000.0 in Q4 2025; TTM through Dec 2025 was $209000.0, a 10.3% decrease from a year earlier, with the FY2025 full-year figure at $209000.0, down 10.3% from the prior year.
- Current Leases was $209000.0 for Q4 2025 at Apollomics, up from $203000.0 in the prior quarter.
- Over five years, Current Leases peaked at $6.3 million in Q4 2021 and troughed at $158000.0 in Q4 2023.
- A 5-year average of $1.0 million and a median of $248500.0 in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases tumbled 90.31% in 2022 and jumped 47.47% in 2024, its largest moves.
- Over 5 years, Current Leases stood at $6.3 million in 2021, then plunged by 90.31% to $614000.0 in 2022, then tumbled by 74.27% to $158000.0 in 2023, then surged by 47.47% to $233000.0 in 2024, then dropped by 10.3% to $209000.0 in 2025.
- The last three Current Leases figures came in at $209000.0 (Q4 2025), $203000.0 (Q2 2025), and $233000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 12.38 Mn |
| 10 | Apollomics | 34.50 Mn | 31.23 Mn | - | 209,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 209,000.00 |
| Jun 30, 2025 | 203,000.00 |
| Dec 31, 2024 | 233,000.00 |
| Jun 30, 2024 | 264,000.00 |
| Dec 31, 2023 | 158,000.00 |
| Jun 30, 2023 | 294,000.00 |
| Dec 31, 2022 | 614,000.00 |
| Dec 31, 2021 | 6.34 Mn |